MTOR and glioblastoma: Indeed, the paradigm of medical treatment of chemotherapy plus radiation therapy has reached an efficacy plateau and several drugs designed to target one of the most deregulated pathways in GBM (PTEN/PI3K/AKT/mTOR) failed to improve the outcome of these patients [2–4].